Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S370400
Reexamination Certificate
active
07863312
ABSTRACT:
The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteoporosis and other destructive bone disease or disorder, and other diseases and disorders associated with the prostaglandin EP2 and/or EP4 receptors.
REFERENCES:
patent: 3873566 (1975-03-01), Scribner
patent: 4211876 (1980-07-01), Scribner
patent: 5605814 (1997-02-01), Abramovitz et al.
patent: 5759789 (1998-06-01), Abramovitz et al.
patent: 6211197 (2001-04-01), Belley et al.
patent: 0 752 421 (1997-01-01), None
patent: 1 114 816 (2001-07-01), None
patent: 1 121 939 (2001-08-01), None
patent: 1 132 086 (2001-09-01), None
patent: 1 428 431 (1976-03-01), None
patent: 96/03380 (1996-02-01), None
patent: 96/06822 (1996-03-01), None
patent: 97/00863 (1997-01-01), None
patent: 97/00864 (1997-01-01), None
Database Crossfire Beilstein ′Online! Beilstein Institut zur Foerderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession No. BRN:5033580 XP002234450 abstract & Chantrapromma, K.; et al.: Chem. Soc. Perkin. Trans. 1, vol. 5, 1983, pp. 1029-1039.
Database Crossfire Beilstein ′Online! Beilstein Institut zur Foerderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession No. BRN: 911732 XP002234451 abstract & J. Pharm: Sci., vol. 58, 1969, pp. 724-727.
Database Crossfire Beilstein ′Online! Beilstein Institut zur Foerderung der Chemischen Wissenschaften, Frankfurt am Main, DE; Database accession No. BRN 1562407 XP002234452 abstract & J. Heterocycl. Chem., vol. 5, 1968, pp. 397-403.
Gregory B. Bennett, et al. Journal of Medicinal Chemistry, vol. 19, No. 5 pp. 709-714 1976.
Stephen L. Tilley, et al. The Journal of Clinical Investigation, vol. 103, No. 11, pp. 1539-1545 1999.
Toshiaki Minami, et al. Br. J. Pharmacol. vol. 112, pp. 735-740 1994.
Araldi Gian Luca
Liao Yihua
Reddy Adulla P.
Zhao Zhong
Merck Serono SA
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Saeed Kamal A
LandOfFree
Pyrazolidinone compounds as ligands of the prostaglandin EP2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolidinone compounds as ligands of the prostaglandin EP2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolidinone compounds as ligands of the prostaglandin EP2... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2669341